Patents/Inventors

Ju Yang

ShenzhenCN27 patents

24 Patents

USD11145402026
Display Stand
SHENZHEN DANCING FUTURE TECHNOLOGY Ltd.
0 cites
USD11132682026
Display Stand
SHENZHEN DANCING FUTURE TECHNOLOGY Ltd.
0 cites
US125333542026
Triaryl Compounds for Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US124973832025
Heteroaryl-biphenyl Amides for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US124483732025
Azetidinyl-acetamides as CXCR7 Inhibitors
AMGEN Inc.
0 cites
US123714332025
Heteroaryl-biphenyl Amines for the Treatment of PD-L1 Diseases
AMGEN Inc.
0 cites
USD10745862025
Earphone Case
SHENZHEN DANCING FUTURE TECHNOLOGY Ltd.
0 cites
USD10669052025
Earphone Case
SHENZHEN DANCING FUTURE TECHNOLOGY Ltd.
0 cites
USD10543972024
Earphone
SHENZHEN DANCING FUTURE TECHNOLOGY Ltd.
0 cites
US121394752024
2-oxindole Compounds
CHEMOCENTRYX, Inc.
0 cites
USD10345392024
Earphone
SHENZHEN DANCING FUTURE TECHNOLOGY Ltd.
0 cites
US120180162024
Aryl Sulfonyl (hydroxy) Piperidines as CCR6 Inhibitors
AMGEN Inc.
0 cites
US120114392024
Combination Therapy Using C—C Chemokine Receptor 4 (CCR4) Antagonists and One or More Immune Checkpoint Inhibitors
CHEMOCENTRYX, Inc.
0 cites
USD10240312024
Earphone
0 cites
US119458052024
Inhibitors of CXCR2
CHEMOCENTRYX, Inc
0 cites
US118846542024
Substituted Anilines as CCR(4) Antagonists
CHEMOCENTRYX, Inc.
0 cites
US118722172024
Indanes as PD-L1 Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US118664292024
Heteroaryl-biphenyl Amines for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US118207592023
Modulators of Chemokine Receptors
CHEMOCENTRYX, Inc.
0 cites
US117937712023
Immunomodulator Compounds
CHEMOCENTRYX, Inc.
0 cites
US117594582023
Indane-amines as PD-L1 Antagonists
CHEMOCENTRYX, Inc.
0 cites
US117133072023
Heteroaryl-biphenyl Amides for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US117083262023
Immunomodulator Compounds
CHEMOCENTRYX, Inc.
0 cites
US116846062023
Methods of Treating Generalized Pustular Psoriasis with an Antagonist of CCR6 or CXCR2
CHEMOCENTRYX, Inc.
0 cites